Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:

NCT ID: NCT05343533 Completed - Depression Clinical Trials

Probiotic Administration on Mood

PAM
Start date: July 17, 2019
Phase: N/A
Study type: Interventional

Researchers are looking to examine the impact of probiotic administration on symptoms commonly associated with depression, anxiety, stress, sleep quality, and associated emotional responses in healthy men and women.

NCT ID: NCT05342116 Completed - Depression Clinical Trials

Carbohydrate Rich Drink Reduces Pre-endoscopic Discomfort for Patients Going for Elective Endoscopic Procedures

Start date: April 4, 2019
Phase: N/A
Study type: Interventional

The study is a randomised controlled trial that aims to evaluate whether carbohydrate loading pre-endoscopy can improve patients' overall satisfaction and is not associated with negative impact on endoscopic quality or increased complications. A questionnaire will be completed by participants prior to endoscopy.

NCT ID: NCT05341297 Completed - Depression Clinical Trials

A Transdiagnostic Internet Intervention for Parents of Children With Anxiety and Depressive Symptoms

ParentKIT
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of a transdiagnostic, parent-led, Internet-delivered intervention in reducing child and adolescent internalizing problems.

NCT ID: NCT05335564 Completed - Depressive Disorder Clinical Trials

Evaluation of a Website to Improve Depression Literacy in Parents of Adolescents With Depression

Start date: January 20, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy and acceptability of the website "ich bin alles" (https://www.ich-bin-alles.de/) to improve depression literacy (knowledge about depression, which aid the recognition, treatment or prevention of depression) in parents of adolescents with acute or remitted depressive disorder. The investigators will examine whether the website improves depression literacy in parents of adolescents aged 12 to 18 years with a history of depression. The investigators will also assess the acceptability of the website among the participants.

NCT ID: NCT05329181 Completed - Clinical trials for Cognitive Behavioral Therapy

Integrated Cognitive Behavioral Treatment for Substance Use and Depressive Symptoms: a Homeless Case Series

INTER
Start date: June 1, 2016
Phase: N/A
Study type: Interventional

This case series and feasibility trial evaluated a novel integrated cognitive behavioral treatment, which was adapted specifically for homeless individuals and developed to treat substance use and depressive symptoms simultaneously. The integrated cognitive behavioral treatment was delivered among four homeless individuals enrolled in the Treatment First program (a social services program where treatment is offered in conjunction with temporary transitional housing), who had access to stable and sober housing milieus.

NCT ID: NCT05326178 Completed - Depressive Disorder Clinical Trials

Evaluation of a Website to Improve Depression Literacy in Parents of Healthy Adolescents

Start date: January 12, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy and acceptability of the website "ich bin alles" (https://www.ich-bin-alles.de/) to improve depression literacy (knowledge about depression, which aid the recognition, treatment or prevention of depression) in parents of healthy adolescents without a mental health condition. The investigators will examine whether the website improves depression literacy in parents of adolescents aged 12 to 18 years without a mental health condition. The investigators will also assess the acceptability of the website among the participants.

NCT ID: NCT05324735 Completed - Clinical trials for Resistant Major Depression

Pentoxifylline for Treatment of Resistant Major Depression

Start date: December 15, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

A growing body of evidence has highlighted the role of inflammation and phosphodiesterases (PDE)-related pathways in the pathogenesis of neuropsychiatric illnesses such as depression/mood disorders. Herein, we aimed to evaluate the therapeutic benefits of pentoxifylline (PTX) in the treatment of therapy-resistant depression (TRD) in adult patients with bipolar depression.

NCT ID: NCT05322811 Completed - Anxiety Clinical Trials

Emotional State Among Patients With Neurological Disorders

Start date: December 1, 2021
Phase:
Study type: Observational

The purpose of the study was to examine the emotional state of the patients with neurological disorders. The evaluation was conducted with DASS-21 scale over 40 patients.

NCT ID: NCT05322161 Completed - Depression Clinical Trials

Yoga in the NICU for Parents Study

YiN
Start date: September 29, 2021
Phase: N/A
Study type: Interventional

The purpose of this proposal is to test the efficacy of yoga as a mind and body intervention to decrease stress, anxiety, and depression in parents of critically ill neonates hospitalized in the Seattle Children's and University of Washington neonatal intensive care units (NICUs).

NCT ID: NCT05318456 Completed - Mood Clinical Trials

The Safety and Efficacy of MoodElite T-4003-1 on Improving Mood in a Healthy Adult Population With Mild to Moderate Depressive Symptoms Not Eligible for Therapeutic Intervention

Start date: March 24, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this study is to investigate the efficacy and safety of MoodElite T-4003-1 on improving mood in a healthy adult population with mild to moderate depressive symptoms not eligible for therapeutic intervention.